IHS Chemical Week

Archives :: Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Displaying 1 - 20 of 1111 stories.
August 22, 2014
Siegfried (Zofingen, Switzerland) reports a 1.6% rise in net profits for the first six months of 2014 compared with the year-ago period, to 18.8 million Swiss francs ($20.5 million)...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Siegfried-reports-a-slight-increase-in-profits_63355.html
August 19, 2014
Perrigo's API segment reports fall in sales and operating profits The active pharmaceutical ingredient (API) business segment of Perrigo (Dublin) reports a 20.5% fall in sales in the...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Pharmafine-chemicals-roundup-19-August-2014_63287.html
August 12, 2014
Galenica (Bern, Switzerland) said today that it is adapting a new management structure. The group will be headed by two CEOs, one in charge of Vifor Pharma, formerly the pharma...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Swiss-health-care-group-Galenica-to-split-into-two-listed-companies_63125.html
August 12, 2014
Daiichi Sankyo to sell API plant at Akita to Japanese firm Pharmaceutical company Daiichi Sankyo (Tokyo) says that it has reached an agreement with finished dosage forms producer...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Pharmafine-chemicals-roundup-12-August-2014_63117.html
August 8, 2014
Pharmaceutical company Daiichi Sankyo (Tokyo) says that it has reached an agreement with finished dosage forms producer Alfresa Pharma (Osaka) to sell the active pharmaceutical...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Daiichi-Sankyo-to-sell-API-plant-at-Akita-to-Japanese-firm_63079.html
August 7, 2014
Codexis (Redwood City, CA), a developer of biocatalysts for the pharmaceutical and fine chemical industries, reports a net loss of $8.47 million in the second quarter of 2014 compared...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Codexis-narrows-loss_63040.html
August 6, 2014
Alvogen (Pine Brook, NJ), a privately owned pharmaceuticals company focused on developing, manufacturing, and distributing generic, OTC, and biosimilar products, announced today that...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Alvogen-acquires-Korean-Dream-Pharma-for-$187-million_63011.html
August 5, 2014
FDA issues warning letter to API producer in China The US FDA issued a warning letter on 9 July to the active pharmaceutical ingredient (API) manufacturing facility of Zhejiang Jiuzhou...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Pharmafine-chemicals-roundup-5-August-2014_62983.html
August 4, 2014
IGM Resins (Charlotte, NC), an ultraviolet inks and coatings firm, has acquired Insight High Technology (IHT; Beijing), a maker of photoinitiators, pharma intermediates, and fine...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Arsenals-IGM-Resins-buys-Chinese-firm_62962.html
August 1, 2014
Custom synthesis firm Isochem (Paris) says it has sold its Framochem (Kazincbarcika, Hungary) subsidiary and its German sales office Isochem Deutschland to fine chemicals company...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Isochem-sells-Hungary-subsidiary-to-US-fine-chemical-firm_62936.html
August 1, 2014
Cambrex (East Rutherford, NJ) reports a more than eightfold increase in net profits for the second quarter of 2014 compared with the second quarter of 2013, to $19.66 million...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Cambrex-reports-huge-rise-in-profits_62924.html
July 30, 2014
The pharmaceutical services and active ingredients (PSAI) business of Dr. Reddy’s Laboratories (Hyderabad, India) reports a 5.6% fall in sales in the company’s fiscal first...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/API-business-of-Dr-Reddys-reports-fall-in-sales_62802.html
July 30, 2014
The US FDA issued a warning letter on 9 July to the active pharmaceutical ingredient (API) manufacturing facility of Zhejiang Jiuzhou Pharmaceutical and its export subsidiary, Zhejiang...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/FDA-issues-warning-letter-to-API-producer-in-China_62798.html
July 29, 2014
Lonza reports huge rise in profits Lonza recorded net profits of 140 million Swiss francs ($155 million) for the first half of 2014 compared with profits of SF41 million in the first...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Pharmafine-chemicals-roundup-29-July-2014_62767.html
July 28, 2014
Following a strategic review announced last October, Consumer goods group Reckitt Benckiser (RB; Slough, UK) said today that it plans to spin off its pharmaceuticals...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Reckitt-Benckiser-to-spin-off-pharmaceuticals-business_62736.html
July 23, 2014
Merck KGaA at today’s press conference at Shanghai affirmed its commitment to China. Merck will in August hold a groundbreaking ceremony for a previously announced €80...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Merck-KGaA-affirms-commitment-to-China-will-break-ground-on-pharma-unit_62655.html
July 18, 2014
The boards of AbbVie (North Chicago, IL) and Shire (Dublin) announced today that they have reached agreement for AbbVie to acquire Shire for approximately £32 billion ($54.7...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/AbbVie-to-acquire-Shire-for-$55-billion_62587.html
July 18, 2014
Mylan (Pittsburgh) has entered into a definitive agreement with Abbott to acquire Abbott's non-US developed markets specialty and branded generics business in an all-stock transaction...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Mylan-to-acquire-Abbotts-non-US-branded-generics-pharma-business_62580.html
July 14, 2014
Biocatalyst firm Codexis (Redwood City, CA) and GlaxoSmithKline (GSK) have announced a license technology agreement worth up to $25 million in initial payments in addition to milestone...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/GlaxoSmithKline-licenses-Codexiss-protein-engineering-platform_62431.html
July 14, 2014
Kyowa Hakko Kirin’s (KHK; Tokyo) subsidiary ProStrakan Group (Galashiels, UK) has agreed with Novo to purchase the entire share capital of Archimedes Pharma (Reading, UK) for...
http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Kyowa-Hakko-Kirin-subsidiary-to-acquire-Archimedes-Pharma_62434.html
Pages:  [1] 2 3 4 5 6 7 8 9 10 Next »










 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2014 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa